Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Polyionic complexes of butyrylcholinesterase and poly-l-lysine-g-poly(ethylene glycol): Comparative kinetics of catalysis and inhibition and in vitro inactivation by proteases and heat.

Hester K, Liu J, Flynn N, Sultatos LG, Geng L, Brimijoin S, Ramsey JD, Hartson S, Ranjan A, Pope C.

Chem Biol Interact. 2017 Sep 25;275:86-94. doi: 10.1016/j.cbi.2017.07.019. Epub 2017 Jul 27.

PMID:
28756151
2.

Altered active zones, vesicle pools, nerve terminal conductivity, and morphology during experimental MuSK myasthenia gravis.

Patel V, Oh A, Voit A, Sultatos LG, Babu GJ, Wilson BA, Ho M, McArdle JJ.

PLoS One. 2014 Dec 1;9(12):e110571. doi: 10.1371/journal.pone.0110571. eCollection 2014.

3.

Acetylcholinesterase deficiency contributes to neuromuscular junction dysfunction in type 1 diabetic neuropathy.

Garcia CC, Potian JG, Hognason K, Thyagarajan B, Sultatos LG, Souayah N, Routh VH, McArdle JJ.

Am J Physiol Endocrinol Metab. 2012 Aug 15;303(4):E551-61. doi: 10.1152/ajpendo.00622.2011. Epub 2012 Jun 26.

4.

Altered binding of thioflavin t to the peripheral anionic site of acetylcholinesterase after phosphorylation of the active site by chlorpyrifos oxon or dichlorvos.

Sultatos LG, Kaushik R.

Toxicol Appl Pharmacol. 2008 Aug 1;230(3):390-6. doi: 10.1016/j.taap.2008.03.006. Epub 2008 Mar 15.

PMID:
18423506
5.

Concentration-dependent binding of chlorpyrifos oxon to acetylcholinesterase.

Sultatos LG.

Toxicol Sci. 2007 Nov;100(1):128-35. Epub 2007 Aug 16.

PMID:
17702992
6.

Concentration-dependent interactions of the organophosphates chlorpyrifos oxon and methyl paraoxon with human recombinant acetylcholinesterase.

Kaushik R, Rosenfeld CA, Sultatos LG.

Toxicol Appl Pharmacol. 2007 Jun 1;221(2):243-50. Epub 2007 Mar 24.

7.

Concentration-dependent kinetics of acetylcholinesterase inhibition by the organophosphate paraoxon.

Rosenfeld CA, Sultatos LG.

Toxicol Sci. 2006 Apr;90(2):460-9. Epub 2006 Jan 10.

PMID:
16403852
8.

Mefloquine inhibits cholinesterases at the mouse neuromuscular junction.

McArdle JJ, Sellin LC, Coakley KM, Potian JG, Quinones-Lopez MC, Rosenfeld CA, Sultatos LG, Hognason K.

Neuropharmacology. 2005 Dec;49(8):1132-9. Epub 2005 Aug 2.

PMID:
16081111
9.

Comparison of chlorpyrifos-oxon and paraoxon acetylcholinesterase inhibition dynamics: potential role of a peripheral binding site.

Kousba AA, Sultatos LG, Poet TS, Timchalk C.

Toxicol Sci. 2004 Aug;80(2):239-48. Epub 2004 May 12.

PMID:
15141101
10.

Incorporation of the genetic control of alcohol dehydrogenase into a physiologically based pharmacokinetic model for ethanol in humans.

Sultatos LG, Pastino GM, Rosenfeld CA, Flynn EJ.

Toxicol Sci. 2004 Mar;78(1):20-31. Epub 2004 Jan 12.

PMID:
14718645
11.

Derivation of occupational exposure limits based on target blood concentrations in humans.

Pastino GM, Kousba AA, Sultatos LG, Flynn EJ.

Regul Toxicol Pharmacol. 2003 Feb;37(1):66-72.

PMID:
12662910
12.
13.

Interactions of rat brain acetylcholinesterase with the detergent Triton X-100 and the organophosphate paraoxon.

Rosenfeld C, Kousba A, Sultatos LG.

Toxicol Sci. 2001 Oct;63(2):208-13.

PMID:
11568364
14.

Methods to identify and characterize developmental neurotoxicity for human health risk assessment. III: pharmacokinetic and pharmacodynamic considerations.

Dorman DC, Allen SL, Byczkowski JZ, Claudio L, Fisher JE Jr, Fisher JW, Harry GJ, Li AA, Makris SL, Padilla S, Sultatos LG, Mileson BE.

Environ Health Perspect. 2001 Mar;109 Suppl 1:101-11. Review.

15.
16.

Genetic polymorphisms in ethanol metabolism: issues and goals for physiologically based pharmacokinetic modeling.

Pastino GM, Flynn EJ, Sultatos LG.

Drug Chem Toxicol. 2000 Feb;23(1):179-201.

PMID:
10711397
17.
18.

Common mechanism of toxicity: a case study of organophosphorus pesticides.

Mileson BE, Chambers JE, Chen WL, Dettbarn W, Ehrich M, Eldefrawi AT, Gaylor DW, Hamernik K, Hodgson E, Karczmar AG, Padilla S, Pope CN, Richardson RJ, Saunders DR, Sheets LP, Sultatos LG, Wallace KB.

Toxicol Sci. 1998 Jan;41(1):8-20. Review.

PMID:
9520337
19.

Mechanisms of drugs that affect uterine motility.

Sultatos LG.

J Nurse Midwifery. 1997 Jul-Aug;42(4):367-70. Review.

PMID:
9277068
20.
21.

Development and application of a physiologically based pharmacokinetic model for ethanol in the mouse.

Pastino GM, Sultatos LG, Flynn EJ.

Alcohol Alcohol. 1996 Jul;31(4):365-74.

PMID:
8879283
22.

Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human placental microsomes.

Collazo NR, Sultatos LG.

Biochem Pharmacol. 1995 Nov 27;50(11):1933-41.

PMID:
8615875
23.

Interaction of ethanol and the organophosphorus insecticide parathion.

O'Shaughnessy JA, Sultatos LG.

Biochem Pharmacol. 1995 Nov 27;50(11):1925-32.

PMID:
8615874
24.

The effects of phenobarbital pretreatment on the metabolism and toxicity of paraoxon in the mouse.

Vitarius JA, O'Shaughnessy JA, Sultatos LG.

Pharmacol Toxicol. 1995 Jul;77(1):16-22.

PMID:
8532607
25.
26.

Mammalian toxicology of organophosphorus pesticides.

Sultatos LG.

J Toxicol Environ Health. 1994 Nov;43(3):271-89. Review.

PMID:
7966438
27.

Solubilization and purification of A-esterase from mouse hepatic microsomes.

Huang YS, Woods L, Sultatos LG.

Biochem Pharmacol. 1994 Sep 15;48(6):1273-80.

PMID:
7945421
28.

Kinetic mechanism of the detoxification of the organophosphate paraoxon by human serum A-esterase.

Vitarius JA, Sultatos LG.

Drug Metab Dispos. 1994 May-Jun;22(3):472-8.

PMID:
8070326
29.

Glutathione-dependent biotransformation of methyl parathion by mouse liver in vitro.

Huang YS, Sultatos LG.

Toxicol Lett. 1993 Jun;68(3):275-84.

PMID:
8516780
30.

Biotransformation of the insecticide parathion by mouse brain.

Soranno TM, Sultatos LG.

Toxicol Lett. 1992 Jan;60(1):27-37.

PMID:
1539180
31.
32.
34.

Evaluation of estimations in vitro of tissue/blood distribution coefficients for organothiophosphate insecticides.

Sultatos LG, Kim B, Woods L.

Toxicol Appl Pharmacol. 1990 Mar 15;103(1):52-5.

PMID:
2315932
35.

Desulfuration of the insecticide parathion by human placenta in vitro.

Sultatos LG, Gagliardi CL.

Biochem Pharmacol. 1990 Feb 15;39(4):799-801. No abstract available.

PMID:
2306284
36.
37.
38.
39.

Metabolic activation of the pesticide azinphos-methyl by perfused mouse livers.

Sultatos LG, Minor LD.

Toxicol Appl Pharmacol. 1987 Sep 15;90(2):227-34.

PMID:
3629598
40.
41.
42.

Factors affecting the biotransformation of the pesticide parathion by the isolated perfused mouse liver.

Sultatos LG, Minor LD.

Drug Metab Dispos. 1986 Mar-Apr;14(2):214-20.

PMID:
2870897
43.

Biotransformation of paraoxon and p-nitrophenol by isolated perfused mouse livers.

Sultatos LG, Minor LD.

Toxicology. 1985 Aug;36(2-3):159-69.

PMID:
4049428
44.

Metabolic activation of phosphorothioate pesticides: role of the liver.

Sultatos LG, Minor LD, Murphy SD.

J Pharmacol Exp Ther. 1985 Mar;232(3):624-8.

PMID:
2579231
45.
46.

The role of hepatic biotransformation in mediating the acute toxicity of the phosphorothionate insecticide chlorpyrifos.

Sultatos LG, Shao M, Murphy SD.

Toxicol Appl Pharmacol. 1984 Mar 30;73(1):60-8.

PMID:
6200955
47.

Mixed-function oxidase studies in the redfish, Sciaenops ocellata, from Galveston Bay, Texas.

Stahl CH, Sultatos LG, Hacker CS, Murphy SD.

Comp Biochem Physiol C. 1984;79(1):177-82.

PMID:
6149864
48.

Effect of trimethyltin on hepatic and extra-hepatic non-protein sulfhydryl levels in the mouse.

Doctor SV, Sultatos LG, Murphy SD.

Toxicol Appl Pharmacol. 1983 Aug;70(1):165-8.

PMID:
6612734
49.

Distribution of trimethyltin in various tissues of the male mouse.

Doctor SV, Sultatos LG, Murphy SD.

Toxicol Lett. 1983 Jun;17(1-2):43-8.

PMID:
6623508
50.

Hepatic microsomal detoxification of the organophosphates paraoxon and chlorpyrifos oxon in the mouse.

Sultatos LG, Murphy SD.

Drug Metab Dispos. 1983 May-Jun;11(3):232-8. No abstract available.

PMID:
6191937

Supplemental Content

Loading ...
Support Center